Key Takeaway: The SURMOUNT-1 efficacy data (20.9% weight loss at 72 weeks) only applies if the compound matches the API Is Tirzepatide Base Really Safer Than Tirzepatide Salts
It is not intended for human consumption, diagnostic use, or therapeutic treatment
Caroline Messer, M.D., a professor of medicine, endocrinology, diabetes, and bone disease at Icahn School of Medicine at Mount Sinai in New York City
Hall, MD, MS, chair of the writing group for the Associations 2021 scientific statement on weight-loss strategies for prevention and treatment of hypertension and chair of the department of medicine at the University of Mississippi Medical Center
Avoiding alcohol, which causes vasodilation and can worsen hypotension, is advisable, particularly during the adjustment period